Off-pump versus on-pump coronary surgery in patients with chronic kidney disease: a meta-analysis

Abstract

Compared with ONCAB, OPCAB is associated with superior postoperative morbidity and the early mortality in CKD patients. Long-term survival is comparable between the two surgical revascularizations.

On-Pump versus Off-Pump Coronary Artery Bypass Grafting in The Surgical Management of High-Risk Patients, A Clinical Randomized Study

“…Wang and colleagues found that there was no difference between off-pump and on-pump regarding early mortality, which run in line with our results [21]. Deppe and colleagues found that there was no difference between off-pump and on-pump groups regarding the 30 days mortality rate [14].…”

Off‐Pump Coronary Artery Bypass Grafting: 30 Years of Debate

“…A meta‐analysis including 17 studies with 201 889 patients with chronic kidney disease associated OPCAB with lower early mortality (OR: 0.88; 95% CI, 0.82–0.93; P <0.0001) and morbidity compared with ONCAB. However, there was no difference regarding long‐term survival (HR: 1.08; 95% CI, 0.86–1.36; P =0.51) 75. A large study based on the National Health Research Institute of Taiwan reported similar outcomes of OPCAB and ONCAB in patients on dialysis 76.…”

Off-Pump Coronary Artery Bypass Grafting: Closing the Communication Gap Across the Ether Screen

“…1 With the advent of cardiac stabilizers that allowed for technical improvements and the realization that specific patient populations benefit from coronary revascularization without the use of CPB, the indications for OPCAB have been expanded to include higher-risk patient populations, including those with end-stage renal disease. 18,19 These include the extreme elderly, females, and patients with severe carotid or aortic atherosclerotic disease. In patients with severe end-organ dysfunction or failure, particularly renal disease and cirrhosis, OPCAB has been shown to reduce morbidity and mortality compared with on-pump bypass techniques.…”